Analysis of mutation signatures from TMZ-treated GBM reveals a role for RAD18 in error-free bypass of O<sup>6</sup>mG (the most toxic TMZ-induced lesion), and error-prone bypass of other TMZ-induced lesions. This evidence concerns the gene RAD18 and glioblastoma.